Key facts
- Gozen’s last known valuation is $10.0M (May 2024).
- It has raised $3.3M; the latest was Early Stage VC in Nov 2025.
- Notable investors include SOSV, IndieBio, Happiness Capital, Accelr8 (Impact Fund Investing), Astor Management — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Gozen
- ·The full record, as it builds
Funding rounds
No funding rounds for Gozen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gozen
Operator of a material science platform intended to create biomaterials for a sustainable future. The company works with microorganisms and agricultural and industrial organic wastes and offers biomaterials developed with a biomimicry approach by combining science and art to produce fully biodegradable, biocompatible, and non-toxic next-generation leather, enabling the fashion industry with a sustainable alternative to leather.
- Sector
- Materials and Resources
- HQ
- San Francisco, CA, United States
- Founded
- 2020
- Employees
- 29
- Website
- gozen.world/
- Ownership
- Privately Held (backing)
Gozen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gozen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gozen in its N-PORT filings yet. We sweep new filings monthly.